The combination of two immunotherapy drugs can reach double life expectancy in patients with a type of aggressive thyroid cancer with no therapeutic alternatives, according to the results of a trial sponsored by the Spanish Neuroendocrine Tumor Group (GETNE). Neuroendocrine tumors, as is the case of thyroid tumor, are rare cancers that can appear in […]
